Anti-Inflammatory and Anti-Oxidative Nutrition in Hypoalbuminemic Dialysis Patients (AIONID) study: Results of the pilot-feasibility, double-blind, randomized, placebo-controlled trial

Journal of Cachexia, Sarcopenia and Muscle

Volumn 4, Issue 4, 2013, Pages 247-257

  Rattanasompattikul, Manoch ^a,b   Molnar, Miklos Z ^a   Lee, Martin L ^c   Dukkipati, Ramanath ^a,b   Bross, Rachelle ^b,d   Jing, Jennie ^a   Kim, Youngmee ^a,e   Voss, Anne C ^f   Benner, Debbie ^g   Feroze, Usama ^a   MacDougall, Iain C ^h   Tayek, John A ^b   Norris, Keith C ⁱ   Kopple, Joel D ^b,j,k   Unruh, Mark ^l   Kovesdy, Csaba P ^m,n   Kalantar Zadeh, Kamyar ^a,b,k  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HARBOR UCLA MEDICAL CENTER   (United States)

^c CHARLES R DREW UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^d LOS ANGELES BIOMEDICAL RESEARCH INSTITUTE   (United States)

^e Chung Ang University   (South Korea)

^f ABBOTT LABORATORIES   (United States)

^g DaVita HealthCare Partners   (United States)

^h KING S COLLEGE HOSPITAL   (United Kingdom)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j UNIVERSITY OF CALIFORNIA   (United States)

^k UNIVERSITY OF CALIFORNIA   (United States)

^l UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^m UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

ⁿ VETERANS AFFAIRS MEDICAL CENTER   (United States)

more..

Author keywords

Albumin; Anti inflammatory ingredients; Anti oxidant ingredients; Hemodialysis; Hypoalbuminemia; Inflammation; Oral nutrition supplements; Protein intake

Indexed keywords

ALBUMIN; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; PENTOXIFYLLINE; PLACEBO;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DRUG TOLERABILITY; FEASIBILITY STUDY; FEMALE; FOOD INTAKE; GASTROINTESTINAL SYMPTOM; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; HYPOALBUMINEMIA; MAINTENANCE HEMODIALYSIS; MAJOR CLINICAL STUDY; MALE; NUTRITIONAL SUPPORT; OBSERVATIONAL STUDY; ORAL NUTRITION SUPPLEMENT; OUTPATIENT; PATIENT SAFETY; PILOT STUDY; PRIORITY JOURNAL; PROTEIN DIET; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION;

EID: 84876718554     PISSN: 21905991     EISSN: 21906009     Source Type: Journal    
DOI: 10.1007/s13539-013-0115-9     Document Type: Article

References (54)

1. Kalantar-Zadeh K, Stenvinkel P, Pillon L, Kopple JD. Inflammation and nutrition in renal insufficiency. Adv Ren Replace Ther. 2003;10: 155-69.
2. Kalantar-Zadeh K, Kopple J. Nutritional management of hemodialysis patients. In: Kopple J, Massry S, editors. Nutritional management of renal disease. 2nd ed. Philadelphia: Lippincott, Williams & Wilkins; 2004. p. 433-66 [chapter].
3. Qureshi AR, Alvestrand A, Divino-Filho JC, Gutierrez A, Heimburger O, Lindholm B, et al. Inflammation, malnutrition, and cardiac disease as predictors of mortality in hemodialysis patients. J Am Soc Nephrol. 2002;13: S28-36.
4. Stenvinkel P. Malnutrition and chronic inflammation as risk factors for cardiovascular disease in chronic renal failure. Blood Purif. 2001;19: 143-51.
5. Stenvinkel P, Chung SH, Heimburger O, Lindholm B. Malnutrition, inflammation, and atherosclerosis in peritoneal dialysis patients. Perit Dial Int. 2001;21: S157-62.
6. Stenvinkel P. Endothelial dysfunction and inflammation-is there a link? Nephrol Dial Transplant. 2001;16: 1968-71.
7. Pecoits-Filho R, Lindholm B, Stenvinkel P. The malnutrition, inflammation, and atherosclerosis (MIA) syndrome-the heart of the matter. Nephrol Dial Transplant. 2002;17: 28-31.
8. Kalantar-Zadeh K, Kopple JD. Relative contributions of nutrition and inflammation to clinical outcome in dialysis patients. Am J Kidney Dis. 2001;38: 1343-50.
9. Kalantar-Zadeh K, Block G, McAllister CJ, Humphreys MH, Kopple JD. Appetite and inflammation, nutrition, anemia and clinical outcome in hemodialysis patients. Am J Clin Nutr. 2004;80: 299-307.
10. Ling PR, Smith RJ, Kie S, Boyce P, Bistrian BR. Effects of protein malnutrition on IL-6-mediated signaling in the liver and the systemic acute-phase response in rats. Am J Physiol Regul Integr Comp Physiol. 2004;287: R801-8.
11. Mak RH, Ikizler AT, Kovesdy CP, Raj DS, Stenvinkel P, Kalantar-Zadeh K. Wasting in chronic kidney disease. J Cachexia, Sarcopenia Muscle. 2011;2: 9-25.
12. Kalantar-Zadeh K, Cano NJ, Budde K, Chazot C, Kovesdy CP, Mak RH, et al. Diets and enteral supplements for improving outcomes in chronic kidney disease. Nat Rev Nephrol. 2011;7: 369-84.
13. Kalantar-Zadeh K, Ikizler TA, Block G, Avram MM, Kopple JD. Malnutrition-inflammation complex syndrome in dialysis patients: causes and consequences. Am J Kidney Dis. 2003;42: 864-81.
14. Ifudu O, Uribarri J, Rajwani I, Vlacich V, Reydel K, Delosreyes G, et al. Low hematocrit may connote a malnutrition-inflammation syndrome in hemodialysis patients. Dial Transplant. 2002;31: 845-78.
15. Kalantar-Zadeh K, Balakrishnan VS. The kidney disease wasting: inflammation, oxidative stress, and diet-gene interaction. Hemodial Int. 2006;10: 315-25.
16. Stenvinkel P, Heimburger O, Lindholm B, Kaysen GA, Bergstrom J. Are there two types of malnutrition in chronic renal failure? Evidence for relationships between malnutrition, inflammation and atherosclerosis (MIA syndrome). Nephrol Dial Transplant. 2000;15: 953-60.
17. Fouque D, Kalantar-Zadeh K, Kopple J, Cano N, Chauveau P, Cuppari L, et al. A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int. 2008;73: 391-8.
18. Rambod M, Bross R, Zitterkoph J, Benner D, Pithia J, Colman S, et al. Association of malnutrition-inflammation score with quality of life and mortality in hemodialysis patients: a 5-year prospective cohort study. Am J Kidney Dis. 2009;53: 298-309.
19. Molnar MZ, Czira ME, Rudas A, Ujszaszi A, Lindner A, Fornadi K, et al. Association of the malnutrition-inflammation score with clinical outcomes in kidney transplant recipients. Am J Kidney Dis. 2011;58: 101-8.
20. Kovesdy CP, George SM, Anderson JE, Kalantar-Zadeh K. Outcome predictability of biomarkers of protein-energy wasting and inflammation in moderate and advanced chronic kidney disease. Am J Clin Nutr. 2009;90: 407-14.
21. Kovesdy CP, Kalantar-Zadeh K. Why is protein-energy wasting associated with mortality in chronic kidney disease? Semin Nephrol. 2009;29: 3-14.
22. Stratton RJ, Bircher G, Fouque D, Stenvinkel P, Mutsert RD, Engfer M, et al. Multinutrient oral supplements and tube feeding in maintenance dialysis: a systematic review and meta-analysis. Am J Kid Dis. 2005;46: 387-405.
23. Caglar K, Fedje L, Dimmitt R, Hakim RM, Shyr Y, Ikizler TA. Therapeutic effects of oral nutritional supplementation during hemodialysis. Kidney Int. 2002;62: 1054-9.
24. Kalantar-Zadeh K, Braglia A, Chow J, Kwon O, Kuwae N, Colman S, et al. An anti-inflammatory and antioxidant nutritional supplement for hypoalbuminemic hemodialysis patients: a pilot/feasibility study. J Ren Nutr. 2005;15: 318-31.
25. Kalantar-Zadeh K, Stenvinkel P, Bross R, Khawar OS, Rammohan M, Colman S, et al. Kidney insufficiency and nutrient-based modulation of inflammation. Curr Opin Clin Nutr Metab Care. 2005;8: 388-96.
26. Kalantar-Zadeh K. Recent advances in understanding the malnutrition-inflammation-cachexia syndrome in chronic kidney disease patients: what is next? Semin Dial. 2005;18: 365-9.
27. Kalantar-Zadeh K. Anti-Inflammatory and Anti-Oxidative Nutrition in Dialysis Patients (AIONID). NCT00561093. 2011. http://clinicaltrials. gov/ct2/show/NCT00561093?term=aionid&rank=1. Accessed 20 June 2013.
28. Kalantar-Zadeh K, Kilpatrick R, Kuwae N, McAllister CJ, Gjertson D, Greenland S, et al. Revisiting mortality-predictability of serum albumin in maintenance hemodialysis patients: population attributable mortality risk for albumin less than 3. 8 mg/L. 12TH International Congress on Nutrition and Metabolism in Renal Disease; Abano Terme (Padova-Venice), June 19-022, 2004. 2004 Jul [abstract].
29. Cockram DB, Hensley MK, Rodriguez M, Agarwal G, Wennberg A, Ruey P, et al. Safety and tolerance of medical nutritional products as sole sources of nutrition in people on hemodialysis. J Ren Nutr. 1998;8: 25-33.
30. Ross. Oxepa®, specialized nutrition for modulating inflammation in the mechanically ventilated, critically ill. Product Handbook, Ross Products, a division of Abbott Laboratories. 2004 (website: http://rpdcon40. ross. com/mn/Ross+MN+Nutritional+Products. nsf/web_Ross. com_XML/ED30B2906CD9C6D0852564FB006E300F?OpenDocument). Accessed 20 June 2013.
31. Pacht ER, DeMichele SJ, Nelson JL, Hart J, Wennberg AK, Gadek JE. Enteral nutrition with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants reduces alveolar inflammatory mediators and protein influx in patients with acute respiratory distress syndrome. Crit Care Med. 2003;31: 491-500.
32. Palombo JD, DeMichele SJ, Boyce PJ, Lydon EE, Liu JW, Huang YS, et al. Effect of short-term enteral feeding with eicosapentaenoic and gamma-linolenic acids on alveolar macrophage eicosanoid synthesis and bactericidal function in rats. Crit Care Med. 1999;27: 1908-15.
33. Maziere C, Dantin F, Conte MA, Degonville J, Ali D, Dubois F, et al. Polyunsaturated fatty acid enrichment enhances endothelial cell-induced low-density-lipoprotein peroxidation. Biochem J. 1998;336: 57-62.
34. Leng GC, Lee AJ, Fowkes FG, Jepson RG, Lowe GD, Skinner ER, et al. Randomized controlled trial of gamma-linolenic acid and eicosapentaenoic acid in peripheral arterial disease. Clin Nutr. 1998;17: 265-71.
35. Rice TW, Wheeler. Thopmson BT, deBoisblanc BP, Steingrub J, Rock P. NHI NHLBI Acute Respiratory Distress Syndrome Network of Investigators. Enteral omega-3 fatty acid, gamma linolenic acid, and antioxidant supplementation in acute lung injury. JAMA. 2011;306: 14: 1574-81. doi: 10. 1001/jama. 2011. 1435.
36. Rudy EB, Vaska PL, Daly BJ, Happ MB, Shiao P. Permuted block design for randomization in a nursing clinical trial. Nurs Res. 1993;42: 287-9.
37. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med. 2002;347: 1557-65.
38. Erbagci AB, Tarakcioglu M, Aksoy M, Kocabas R, Nacak M, Aynacioglu AS, et al. Diagnostic value of CRP and Lp(a) in coronary heart disease. Acta Cardiol. 2002;57: 197-204.
39. Pecoits-Filho R, Barany P, Lindholm B, Heimburger O, Stenvinkel P. Interleukin-6 is an independent predictor of mortality in patients starting dialysis treatment. Nephrol Dial Transplant. 2002;17: 1684-8.
40. Stenvinkel P, Heimburger O, Jogestrand T. Elevated interleukin-6 predicts progressive carotid artery atherosclerosis in dialysis patients: association with Chlamydia pneumoniae seropositivity. Am J Kidney Dis. 2002;39: 274-82.
41. Beutler B, Cerami A. The biology of cachectin/TNF-a primary mediator of host response. Ann Rev Immunol. 1989;7: 625-55.
42. Stenvinkel P, Heimburger O, Paultre F, Diczfalusy U, Wang T, Berglund L, et al. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int. 1999;55: 1899-911.
43. Mehrotra R, Duong U, Jiwakanon S, Kovesdy CP, Moran J, Kopple JD, et al. Serum albumin as a predictor of mortality in peritoneal dialysis: comparisons with hemodialysis. Am J Kidney Dis. 2011;58: 418-28.
44. Molnar MZ, Kovesdy CP, Bunnapradist S, Streja E, Mehrotra R, Krishnan M, et al. Associations of pretransplant serum albumin with post-transplant outcomes in kidney transplant recipients. Am J Transplant. 2011;11: 1006-15.
45. Friedman AN, Fadem SZ. Reassessment of albumin as a nutritional marker in kidney disease. J Am Soc Nephrol. 2010;21: 223-30.
46. Kaysen GA, Dubin JA, Muller HG, Mitch WE, Rosales LM, Levin NW. Relationships among inflammation nutrition and physiologic mechanisms establishing albumin levels in hemodialysis patients. Kidney Int. 2002;61: 2240-9.
47. de Mutsert R, Grootendorst DC, Indemans F, Boeschoten EW, Krediet RT, Dekker FW. Association between serum albumin and mortality in dialysis patients is partly explained by inflammation, and not by malnutrition. J Ren Nutr. 2009;19: 127-35.
48. Rigaud D, Hassid J, Meulemans A, Poupard AT, Boulier A. A paradoxical increase in resting energy expenditure in malnourished patients near death: the king penguin syndrome. Am J Clin Nutr. 2000;72: 355-60.
49. Braun TP, Marks DL. Pathophysiology and treatment of inflammatory anorexia in chronic disease. J Cachexia Sarcopenia Muscle. 2010;1: 135-45.
50. Ikizler TA. Effects of hemodialysis on protein metabolism. J Ren Nutr. 2005;15: 39-43.
51. Pupim LB, Majchrzak KM, Flakoll PJ, Ikizler TA. Intradialytic oral nutrition improves protein homeostasis in chronic hemodialysis patients with deranged nutritional status. J Am Soc Nephrol. 2006;17: 3149-57.
52. Sundell MB, Cavanaugh KL, Wu P, Shintani A, Hakim RM, Ikizler TA. Oral protein supplementation alone improves anabolism in a dose-dependent manner in chronic hemodialysis patients. J Ren Nutr. 2009;19: 412-21.
53. Kovesdy CP, Kalantar-Zadeh K. Oral bicarbonate: renoprotective in CKD? Nat Rev Nephrol. 2010;6: 15-7.
54. US Renal Data System, USRDS 2011 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. Bethesda, MD; 2011.